Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin and Danazol for Steroid-resistant/Relapse ITP
NCT05353673Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jun 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
sitagliptin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05353673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05353673.